{
  "id": 14231167,
  "title": "FTC says Martin Shkreli 'flagrantly and repeatedly' violated his lifetime pharma ban",
  "url": "https://urgent.news/2026/10/13/ftc-says-martin-shkreli-flagrantly-and-repeatedly-violated-his",
  "topic": "world",
  "section": "World",
  "published": "2026-10-13T15:21:47.000Z",
  "source": {
    "name": "Business Insider",
    "slug": "business-insider",
    "url": "https://www.businessinsider.com/ftc-martin-shkreli-lifetime-pharma-ban-contempt-2026-10"
  },
  "original_language": "en",
  "account": "The Federal Trade Commission (FTC) and seven state attorneys general have accused pharmaceutical industry figure Martin Shkreli of repeatedly violating his lifetime ban from the industry. Despite being ordered to refrain from engaging in pharmaceutical activities, Shkreli, also known as the \"Pharma Bro,\" has continued to trade pharmaceutical stocks and publicly comment on the industry. The FTC and attorneys general have filed a 37-page court document, requesting that a judge hold Shkreli in contempt for his violations. They are also seeking to impose fines on any profits he made from pharma-related trades, as well as enforce increasingly harsh consequences for any future breaches of the ban. Shkreli, who served four years in prison for securities fraud in 2017, was ordered to pay a $64.6 million penalty and receive a lifetime ban from the industry upon his release in 2022. Since his release, he has actively engaged in pharmaceutical stock trading and livestreams, even holding a trading challenge in July 2022 using a $10 million account to trade in 11 pharmaceutical stocks, including major players like Pfizer and Moderna.",
  "summary": "The Federal Trade Commission and seven state attorneys general want a federal judge to find Martin Shkreli in contempt.",
  "key_points": [],
  "editors_take": null,
  "illustration": "https://urgent.news/ill/14231167.png",
  "coverage": {
    "outlets": 6,
    "also_reported_by": [
      {
        "outlet": "CNBC",
        "title": "Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim",
        "url": "https://urgent.news/2026/10/13/martin-shkreli-violated-lifetime-pharma-industry-ban-ftc-and-states",
        "published": "2026-10-13T13:01:43.000Z"
      },
      {
        "outlet": "Quartz",
        "title": "FTC and 7 states are seeking to hold Martin Shkreli in contempt over pharma ban",
        "url": "https://urgent.news/2026/10/13/ftc-and-7-states-are-seeking-to-hold-martin-shkreli-in-contempt-over",
        "published": "2026-10-13T13:30:26.000Z"
      },
      {
        "outlet": "STAT News",
        "title": "STAT+: FTC demands Martin Shkreli divest his pharma stocks",
        "url": "https://urgent.news/2026/10/13/stat-ftc-demands-martin-shkreli-divest-his-pharma-stocks",
        "published": "2026-10-13T14:31:08.000Z"
      },
      {
        "outlet": "MarketWatch Top",
        "title": "‘Pharma Bro’ Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks",
        "url": "https://urgent.news/2026/10/13/pharma-bro-martin-shkreli-is-in-trouble-with-regulators-again-this",
        "published": "2026-10-13T15:37:00.000Z"
      },
      {
        "outlet": "The Guardian US",
        "title": "FTC and seven states seek contempt ruling against Shkreli over pharma ban",
        "url": "https://urgent.news/2026/10/13/ftc-and-seven-states-seek-contempt-ruling-against-shkreli-over-pharma",
        "published": "2026-10-13T16:54:11.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}